Summary
We have examined the associations between levels of plasma apolipoprotein (apo) AI, apo CIII and apo AIV and genetic variation in the apo AI-CIII-AIV gene cluster in 162 boys and young men from Belgium aged from 7 to 23 years. Genotypes were determined for six restriction enzymes XmnI, PstI, SstI, PvwIIA-CIII, PvuIIB-AIV and XbaI, and for the G to A substitution at -75 bp in the 5′ region of the apo AI gene. The polymorphism most strongly associated with apo AI levels was the G to A substitution (P=0.025, R 2×100=3.6%) confirming previous observations. The polymorphism most strongly associated with apo CIII levels was that of PvwIIA-CIII (P=0.023, R 2×100=2.9%) in the apo CIII gene. This novel association must be interpreted with caution until it has been confirmed in an independent sample. The polymorphism associated with the largest effect on apo AIV levels was that detected with XbaI in the apo AIV gene, but this association was not statistically significant. Previously reported associations between the SstI polymorphism and triglyceride levels, and between the PstI polymorphism and apo AI levels, were weakly detected in the present sample. Our results show that variation associated with some of the polymorphisms in the apo AI-CIII-AIV cluster makes a small, but statistically significant, contribution to the determination of apo AI and apo CIII levels in this sample of young men and boys. These observations may, in part, explain reported associations between polymorphisms in this gene cluster, differences in plasma lipid and lipoprotein levels, and prevalence of coronary artery disease.
Similar content being viewed by others
References
Allain CC, Poon LS, Chan CS (1974) Enzymatic determination of total cholesterol. Clin Chem 20:470–475
Anderson RA, Burns TL, Lee J, Swenson D, Bristow JL (1989) Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population. Atherosclerosis 77:227–237
Antonarakis SE, Oettgen P, Chakravarti A, Halloran SL, Hudson RR, Feisee L, Karathanasis SK (1988) DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet 80:265–273
Berenson GS, Srinivasan SR, Cresanta JL, Foster TA, Webber LS (1981) Dynamic changes in serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol 113:157–170
Benlian C, Boileau C, Loux N, Pastier D, Masliah J, Coulon M, Nigou M, Ragab A, Guimard J, Ruidavets JB, Bonalti-Pellie C, Fruchart JC, Douste-Blazy P, Bereziat G, Junien C (1991) Extended haplotypes and linkage disequilibrium between 11 markers at the Apo AI-C3-A4 gene cluster on chromosome 11. Am J Hum Genet 48:903–910
Berg A, Frey I, Keul J (1986) Apolipoprotein profile in healthy males and its relation to maximum aerobic capacity (MAC). Clin Chim Acta 161:165–171
Brown WV, Baginsky ML (1972) Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 46:375–381
Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock MF, Marcel YL, Milne RW, Koizumi J, Mabachi H, Takeda R, Tall AR (1989) Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature 342:448–451
Bucolo GH, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476–482
Bury J, Rosseneu M (1988) Apolipoprotein quantitation by ELISA: technical aspects and clinical applications. Rev Immunoassay Techn 1:1–25
Chakravarti A, Phillips JA, Mellits KH, Buetow KH, Seeburg PH (1984) Patterns of polymorphism and linkage disequilibrium suggest independent origins of the human growth hormone gene cluster. Proc Natl Acad Sci USA 81:6085–6089
Coleman RT, Gonzales PA, Funke H, Assman G, Levy-Wilson B, Frossard PM (1986) Polymorphisms in the apolipoprotein AI-CIII complex. Mol Biol Med 3:213–228
Delmatre JG, Hoffmeier CA, Lacko AG, Roheim PS (1983) Distribution of apolipoprotein AIV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin cholesterol acyltransferase. J Lipid Res 24:1578–1585
Eckardstein A, Funke H, Henke A, Altland K, Benninghoven A, Assman G (1989) Apolipoprotein AI variants, naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J Clin Invest 84:1722–1730
Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Green PHR, Glickman RM, Sandek CD, Blum CB, Tall AR (1979) Human intestinal lipoprotein: studies in chyluric subjects. J Clin Invest 64:233–242
Green PHR, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65:911–919
Haffner SM, Applebaum-Bowden D, Wahl PW, Hoover JJH, Warnick GR, Albers JJ, Hazzard WR (1985) Epidemiological correlates of high density lipoprotein subfractions, apolipoprotein AI, AII and D and lecithin cholesterol acyltransferase: effects of smoking, alcohol and adiposity. Arteriosclerosis 5:169–177
Hamsten A, Iselius L, Dahlen G, Fraire U (1986) Genetic and cultural inheritance of serum lipids low and high density lipoprotein cholesterol and serum apolipoproteins AI, AII and B. Atherosclerosis 60:199–208
Hartung GH, Reeves RS, Foreyt JP, Patsch W, Gotto AM (1986) Effect of alcohol intake and exercise on plasma high density lipoprotein cholesterol subfractions and apolipoprotein AI in women. Am J Cardiol 58:148–151
Herbert PN, Assman G, Gotto AM Jr, Fredrickson DS (1983) Familial lipoprotein deficiency: abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease. In: Stanbury JB, Wyngaarten JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 589–621
Humphries SE (1988) DNA polymorphisms of the apolipoprotein genes — their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 72:89–108
Jeenah M, Kessling A, Miller N, Humphries SE (1990) A G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 7:233–241
Jones KA, Yamamoto KR, Tjian R (1985) Two distinct transcription factors bind to HSV thymidine kinase promoter in vitro. Cell 42:559–572
Kadonaga JT, Jones KA, Tjian R (1986) Promoter-specific activation of RNA polymerase II transcription by SP1. Trends Biochem Sci 11:20–23
Karathanasis SK, McPherson J, Zannis VI, Breslow JL (1983) Linkage of human apolipoprotein AI and CIII genes. Nature 304:371–373
Karathanasis SK, Yunis J, Zannis VI (1986a) Structure, evolution and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry 25:3962–3970
Karathanasis SK, Oettgen P, Haddad IA, Antonarakis SE (1986b) Structure, evolution and polymorphisms of the human apolipoprotein A4 gene (apoA4). Proc Natl Acad Sci USA 83:8457–8461
Karathanasis SK, Ferris E, Hadda IA (1987) DNA Inversion within the apolipoprotein AI-CIII-AIV gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 82:6374–6378
Kessling AM, Horsthemke B, Humphries SE (1985) A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet 28:296–306
Kessling AM, Rajput-Williams J, Bainton D, Scott J, Miller N, Baker I, Humphries SE (1988a) DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high density lipoprotein cholesterol concentration. Am J Hum Genet 42:458–467
Kessling AM, Temple A, Taylor A, Hutson J, Hidalgo A, Hidalgo A, Humphries SE (1988b) A PvuII polymorphism in the 5′ flanking region of the apo AIV gene: detection of genetic variation determining apo AI and HDL-cholesterol concentration. Hum Genet 78:237–239
Kinnunen PK, Virtanen JA, Vainio P (1983) Lipoprotein lipase and hepatic endothelial lipase: their role in plasma lipoprotein metabolism. Atheroscler Rev 7:65–105
Knijff F, Rosseneu M, Beisiegel U, Keersgieter W, Frants RR, Havekes LM (1988) Apolipoprotein AIV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29:1621–1627
Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones W Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249
Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M (1987) Inheritance of high density lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 4:421–425
Lusis AJ (1988) Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 29:397–429
Menzel HJ, Boerwinkel E, Schrangel-Will S, Utermann G (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79:368–372
Miller NE, Forde OH, Fhelle DS, Mjos OD (1977) The Trømsø heart study. High density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1:965–968
Moll PP, Michel VV, Weidman WH, Kottke BA (1989) Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet 44:24–139
Morrison JA, Laskarzewsk PM, Rauh JL, Brookman R, Mellies M, Frazer M, Khovry P, De Groot I, Kelly K, Glueck CJ (1979) Lipids, lipoproteins and sexual maturation during adolescence: the Princeton maturation study. Metabolism 28:641
Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P (1982) Familial deficiency of apolipoproteins AI and CIII and precocious coronary-artery disease. N Engl J Med 306:1513–1519
Norusis MJ (1986) SPSS/PC+ for the IBM PC/XT/AT. SPSS, Chicago
Oettgen P, Antonarakis SE, Karathanasis SK (1986) PvuII polymorphic site upstream to the human apo CIII gene. Nucleic Acids Res 14:557
Oram JF, Johnson CT, Brown TA (1987) Interaction of highdensity lipoprotein with its receptor on cultured fibroblasts and macrophages. Biol Chem 262:2405–2410
Orchard TJ, Rodgers M, Hedley AJ, Mitchell JR (1981) Serum lipids in a teenage population: geographical, seasonal and familial factors. Int J Epidemiol 10:161
Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PWF, Salem DN, Ward RH, Schaefer EJ (1991) Restriction fragment length polymorphisms of the apolipoprotein AI, CIII, AIV gene locus. Relationships with lipids, apolipoproteins and premature coronary artery disease. Atherosclerosis 87:75–86
Pagani F, Sidoli A, Guidici GA, Barenghi L, Vergani C, Baralle FE (1990) Human apolipoprotein AI promotor polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 31:1371–1377
Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F (1988) Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis 73:125–133
Quarfordt SH, Michalopoulos G, Schirmer B (1982) The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat. J Biol Chem 257:14642–14647
Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ (1985) DNA polymorphism in the apo-A-I-C-III gene cluster: association with hypertri-glyceridaemia. J Clin Invest 76:1090–1095
Rosseneu M, Van Biervliet JP, Bury J, Vinaimont N (1983) Isolation and characterization of lipoprotein profiles in newborns by density-gradient ultracentrifugation. Pediat Res 17:788–794
Rosseneu M, Michiels G, De Keersgieter W, Bury J, De Slijpere JP, Utermann G, Dieplinger H (1988) Human apolipoprotein A-IV quantitation by sandwich enzyme-linked immunosorbent assay. Clin Chem 34:739–743
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich H (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Sastry KN, Seedorf U, Karathanasis SK (1988) Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 8:605–614
Schmitz G, Niemann R, Brennhausen B, Krause R, Assman G (1985) Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA: cholesterol acyltransferase. EMBO J 4:2773–2779
Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ (1991) Variation at the apo AI-CIII-AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 87:239–247
Sokal RR, Rohlf G (1983) Biometry, 2nd edn. Freeman, San Francisco
Steinmetz A, Utermann G (1985) Activation of lecithin: cholesterol acyltransferase by human apolipoprotein AIV. J Biol Chem 260:2258–2264
Thompson EA, Deeb S, Walker D, Motulsky AG (1988) The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113–124
Vercaemst R, Rosseneu M, Van Biervliet JP (1983) Separation and of plasma lipoproteins by high-performance liquid chromatography. J Chromatogr 276:174–181
Vermeulen A (1973) The endocrine function of the human testis. In: James VHT, Seno M, Martino L (eds). Academic Press, New York, pp 91–103
Wile DB, Barbir M, Gallagher J, Myant NB, Ritchie CD, Thompson GR, Humphries SE (1989) Apolipoprotein AI gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo AI and HDL-cholesterol concentration. Atherosclerosis 78:9–18
Yaari S, Even-Zohar S, Goldbourt U, Neufeld HN (1981) Associations of serum high-density lipoprotein and total cholesterol with total, cardiovascular and cancer mortality in a 7-year prospective study of 10000 men. Lancet 1:1011–1013
Xu C-F, Nanjee MN, Savill J, Talmud P, Angelico F, Del Ben M, Antonini R, Mazzarella B, Miller N, Humphries SE (1990) Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet 47:429–439
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paul-Hayase, H., Rosseneu, M., Robinson, D. et al. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88, 439–446 (1992). https://doi.org/10.1007/BF00215679
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00215679